OrsoBio, Inc.

formerly Orso Bio

Advancing first-in-class therapies to restore energy homeostasis

Menlo Park, United States · Founded 2022 · $127.0M raised

Employees
1–10
Founded
2022
Business Model
B2B
Total Funding
$127.0M
Last Round
$67.0M Series BSep 2024
Rounds
2

About

OrsoBio is a clinical-stage biopharmaceutical company developing first-in-class therapies to address the underlying causes of organ dysfunction in patients with severe metabolic disorders, including type 2 diabetes, severe dyslipidemias, lipodystrophies, obesity, and nonalcoholic steatohepatitis (MASH). The company has four programs in clinical and preclinical development targeting central pathways in energy metabolism. OrsoBio's name is inspired by the remarkable metabolic adaptability of bears ("orso" in Italian) and its mission is to restore energy homeostasis in patients with severe metabolic disorders.

Summary

OrsoBio, Inc. is a Biotech company based in Menlo Park, United States, founded in 2022. It has raised $127.0M in total across 2 rounds, most recently a $67.0M Series B round in Sep 2024. Investors include Ascenta Capital, Woodline Partners and Longitude Capital.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BSep 2024
$67.0M

Sign up to see all 2 rounds

Series A through Series B — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

OrsoBio, Inc. on Indexed.vc
<a href="https://indexed.vc/companies/orsobio-inc"><img src="https://indexed.vc/api/badge/company/orsobio-inc" alt="OrsoBio, Inc. on Indexed.vc" width="260" height="76" /></a>